{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:12:35Z","timestamp":1790190755606,"version":"4.1.0"},"reference-count":260,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T00:00:00Z","timestamp":1567555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008793","name":"Universidad del Rosario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jtauto.2019.100015","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T19:17:08Z","timestamp":1567797428000},"page":"100015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Identifying the culprits in neurological autoimmune diseases"],"prefix":"10.1016","volume":"2","author":[{"given":"Yeny","family":"Acosta-Ampudia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Monsalve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Ram\u00edrez-Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2019.100015_bib1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.autrev.2012.02.002","article-title":"Common mechanisms of autoimmune diseases (the autoimmune tautology)","volume":"11","author":"Anaya","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2019.100015_bib2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"GBD 2016 Neurology Collaborators, Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","year":"2019","journal-title":"Lancet. Neurol"},{"key":"10.1016\/j.jtauto.2019.100015_bib3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/0976500X20130205","article-title":"The portal for rare diseases and orphan drugs","volume":"4","author":"Singh","year":"2013","journal-title":"J.\u00a0Pharmacol. Pharmacother."},{"key":"10.1016\/j.jtauto.2019.100015_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.msard.2017.03.014","article-title":"Vitamin D and multiple sclerosis: an update","volume":"14","author":"Pierrot-Deseilligny","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jtauto.2019.100015_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-0038-1660820","article-title":"Infection, immunodeficiency, and inflammatory diseases in autoimmune neurology","volume":"38","author":"Piquet","year":"2018","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.jtauto.2019.100015_bib6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.amjmed.2017.10.033","article-title":"Autoimmune neurologic disorders","volume":"131","author":"Rubin","year":"2018","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jtauto.2019.100015_bib7","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1474-4422(10)70094-6","article-title":"Multiple sclerosis: risk factors, prodromes, and potential causal pathways","volume":"9","author":"Ramagopalan","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jtauto.2019.100015_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","article-title":"T\u00a0cells in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"162","author":"Fletcher","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0074-7742(07)79004-9","article-title":"The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?","volume":"79","author":"Johnson","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.jtauto.2019.100015_bib10","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jtauto.2019.100015_bib11","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barre syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jtauto.2019.100015_bib12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jtauto.2019.100015_bib13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaut.2013.12.001","article-title":"Genetic basis of myasthenia gravis - a comprehensive review","volume":"52","author":"Avidan","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jtauto.2019.100015_bib14","first-page":"874680","article-title":"Myasthenia gravis: a review","volume":"2012","author":"Jayam Trouth","year":"2012","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.jtauto.2019.100015_bib15","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A\u00a0role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jtauto.2019.100015_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/WNO.0000000000000508","article-title":"Neuromyelitis optica: deciphering a complex immune-mediated astrocytopathy","volume":"37","author":"Bennett","year":"2017","journal-title":"J.\u00a0Neuro Ophthalmol."},{"key":"10.1016\/j.jtauto.2019.100015_bib17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrg.2015.33","article-title":"Autoimmune diseases - connecting risk alleles with molecular traits of the immune system","volume":"17","author":"Gutierrez-Arcelus","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jtauto.2019.100015_bib18","series-title":"Ina. Soc. Hum. Genet. 2016 Annu. Meet","article-title":"200 Loci complete the genetic puzzle of multiple sclerosis","author":"Patsopoulos","year":"2016"},{"key":"10.1016\/j.jtauto.2019.100015_bib19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nri2554","article-title":"From genes to function: the next challenge to understanding multiple sclerosis","volume":"9","author":"Fugger","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fimmu.2017.00425","article-title":"The multiple sclerosis (MS) genetic risk factors indicate both acquired and innate immune cell subsets contribute to MS pathogenesis and identify novel therapeutic opportunities","volume":"8","author":"Parnell","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147567","article-title":"Identifying patient-specific epstein-barr nuclear antigen-1 genetic variation and potential autoreactive targets relevant to multiple sclerosis pathogenesis","volume":"11","author":"Tschochner","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2019.100015_bib22","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/ng.3395","article-title":"Class II HLA interactions modulate genetic risk for multiple sclerosis","volume":"47","author":"Moutsianas","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jtauto.2019.100015_bib23","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1038\/ncomms6056","article-title":"Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells","volume":"5","author":"Hartmann","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtauto.2019.100015_bib24","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/s41598-017-01345-8","article-title":"Variants in the IL7RA gene confer susceptibility to multiple sclerosis in Caucasians: evidence based on 9734 cases and 10436 controls","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2019.100015_bib25","doi-asserted-by":"crossref","first-page":"E2973","DOI":"10.1073\/pnas.1524924113","article-title":"Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation","volume":"113","author":"Gross","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.jtauto.2019.100015_bib26","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4103\/0366-6999.226892","article-title":"Variant of EOMES associated with increasing risk in Chinese patients with relapsing-remitting multiple sclerosis","volume":"131","author":"Chen","year":"2018","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.jtauto.2019.100015_bib27","doi-asserted-by":"crossref","first-page":"291ra93","DOI":"10.1126\/scitranslmed.aaa9223","article-title":"Genetic variants associated with autoimmunity drive NFkappaB signaling and responses to inflammatory stimuli","volume":"7","author":"Housley","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jtauto.2019.100015_bib28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barre syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jtauto.2019.100015_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0404.2009.01229.x","article-title":"Immunoglobulin IgG Fc-receptor polymorphisms and HLA class II molecules in Guillain-Barre syndrome","volume":"122","author":"Sinha","year":"2010","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jtauto.2019.100015_bib30","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.4049\/jimmunol.170.6.3074","article-title":"Differential distribution of HLA-DQ beta\/DR beta epitopes in the two forms of Guillain-Barre syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP): identification of DQ beta epitopes associated with susceptibil","volume":"170","author":"Magira","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/cmi.2017.142","article-title":"Guillain\u2013Barr\u00e9 syndrome, transverse myelitis and infectious diseases","volume":"15","author":"Rodr\u00edguez","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jneuroim.2011.12.003","article-title":"The effect of TNF-alpha, FcgammaR and CD1 polymorphisms on Guillain-Barre syndrome risk: evidences from a meta-analysis","volume":"243","author":"Wu","year":"2012","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib33","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.410440517","article-title":"Genetic contribution of the tumor necrosis factor region in Guillain-Barre syndrome","volume":"44","author":"Ma","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jtauto.2019.100015_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000102162","article-title":"Association of tumor necrosis factor polymorphisms with Guillain-Barre syndrome","volume":"58","author":"Zhang","year":"2007","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jtauto.2019.100015_bib35","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.humimm.2010.06.013","article-title":"Tumor necrosis factor-alpha polymorphisms and expression in Guillain-Barre syndrome","volume":"71","author":"Prasad","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneuroim.2007.07.008","article-title":"Genetic polymorphisms of macrophage-mediators in Guillain-Barre syndrome","volume":"190","author":"Geleijns","year":"2007","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2005.01.016","article-title":"Severity of Guillain-Barre syndrome is associated with Fc gamma Receptor III polymorphisms","volume":"162","author":"van Sorge","year":"2005","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jneuroim.2007.03.001","article-title":"Polymorphisms of CD1 genes in chronic dysimmune neuropathies","volume":"186","author":"De Angelis","year":"2007","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib39","doi-asserted-by":"crossref","first-page":"15464","DOI":"10.1073\/pnas.0406756101","article-title":"Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia","volume":"101","author":"Vandiedonck","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.jtauto.2019.100015_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jneuroim.2012.03.018","article-title":"HLA-DQA1*03:02\/DQB1*03:03:02 is strongly associated with susceptibility to childhood-onset ocular myasthenia gravis in Southern Han Chinese","volume":"247","author":"Zhu","year":"2012","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036603","article-title":"Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population","volume":"7","author":"Maniaol","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2019.100015_bib42","first-page":"541760","article-title":"Association of HLA-DQB1 *05:02 and DRB1 *16 alleles with late-onset, nonthymomatous, AChR-ab-positive myasthenia gravis","volume":"2012","author":"Testi","year":"2012","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.jtauto.2019.100015_bib43","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.humimm.2009.04.027","article-title":"The autoimmunity-related polymorphism PTPN22 1858C\/T is associated with anti-titin antibody-positive myasthenia gravis","volume":"70","author":"Greve","year":"2009","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib44","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0165-5728(98)00253-7","article-title":"Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis","volume":"94","author":"Huang","year":"1999","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib45","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3389\/fneur.2018.00529","article-title":"IL-4Ralpha polymorphism is associated with myasthenia gravis in Chinese han population","volume":"9","author":"Jiang","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jtauto.2019.100015_bib46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.gene.6364041","article-title":"Association of the gene encoding the delta-subunit of the muscle acetylcholine receptor (CHRND) with acquired autoimmune myasthenia gravis","volume":"5","author":"Giraud","year":"2004","journal-title":"Genes Immun."},{"key":"10.1016\/j.jtauto.2019.100015_bib47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jneuroim.2003.08.043","article-title":"Association of the Fc gamma receptor IIA-R\/R131 genotype with myasthenia gravis in Dutch patients","volume":"144","author":"van der Pol","year":"2003","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0165-5728(97)00161-6","article-title":"Polymorphisms in IL-1beta and IL-1 receptor antagonist genes are associated with myasthenia gravis","volume":"81","author":"Huang","year":"1998","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib49","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0165-5728(98)00228-8","article-title":"Markers in the promoter region of interleukin-10 (IL-10) gene in myasthenia gravis: implications of diverse effects of IL-10 in the pathogenesis of the disease","volume":"94","author":"Huang","year":"1999","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jneuroim.2018.03.008","article-title":"Evidence for association of STAT4 and IL12RB2 variants with Myasthenia gravis susceptibility: what is the effect on gene expression in thymus?","volume":"319","author":"Zagoriti","year":"2018","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib51","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1212\/WNL.56.3.317","article-title":"Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica","volume":"56","author":"Mirsattari","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2019.100015_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2017.05.018","article-title":"The HLA DRB1*03:01 allele is associated with NMO regardless of the NMO-IgG status in Brazilian patients from Rio de Janeiro","volume":"310","author":"Alvarenga","year":"2017","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jneuroim.2016.02.006","article-title":"Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel","volume":"293","author":"Brill","year":"2016","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1352458511417480","article-title":"HLA, PTPN22 and PD-1 associations as markers of autoimmunity in neuromyelitis optica","volume":"18","author":"Asgari","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jtauto.2019.100015_bib55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/cen3.12078","article-title":"Genetic studies of multiple sclerosis and neuromyelitis optica: current status in European, African American and Asian populations","volume":"5","author":"Isobe","year":"2014","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib56","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jneuroim.2010.11.004","article-title":"HLA-DPB1 0501 is associated with susceptibility to anti-aquaporin-4 antibodies positive neuromyelitis optica in southern Han Chinese","volume":"233","author":"Wang","year":"2011","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib57","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jneuroim.2014.07.003","article-title":"Human aquaporin 4 gene polymorphisms in Chinese patients with neuromyelitis optica","volume":"274","author":"Wei","year":"2014","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib58","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s12017-017-8463-9","article-title":"STAT4 polymorphisms are associated with neuromyelitis optica spectrum disorders","volume":"19","author":"Shi","year":"2017","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.jtauto.2019.100015_bib59","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.nbd.2009.10.013","article-title":"Common CYP7A1 promoter polymorphism associated with risk of neuromyelitis optica","volume":"37","author":"Kim","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jtauto.2019.100015_bib60","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jns.2011.11.005","article-title":"Interleukin 17 gene polymorphism is associated with anti-aquaporin 4 antibody-positive neuromyelitis optica in the Southern Han Chinese--a case control study","volume":"314","author":"Wang","year":"2012","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.jtauto.2019.100015_bib61","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1017\/S0317167100014001","article-title":"CD226 Gly307Ser association with neuromyelitis optica in Southern Han Chinese","volume":"39","author":"Liu","year":"2012","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.jtauto.2019.100015_bib62","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1007\/s12035-016-0070-5","article-title":"Association of CD40 gene polymorphisms with susceptibility to neuromyelitis optica spectrum disorders","volume":"54","author":"Shi","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jtauto.2019.100015_bib63","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jneuroim.2017.05.003","article-title":"Association of CD58 gene polymorphisms with NMO spectrum disorders in a Han Chinese population","volume":"309","author":"Liu","year":"2017","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib64","first-page":"246","article-title":"Role of epigenetics in biology and human diseases","volume":"20","author":"Moosavi","year":"2016","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.jtauto.2019.100015_bib65","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13148-019-0632-2","article-title":"The emerging role of epigenetics in human autoimmune disorders","volume":"11","author":"Mazzone","year":"2019","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.jtauto.2019.100015_bib66","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/ng1068","article-title":"DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells","volume":"33","author":"Robert","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jtauto.2019.100015_bib67","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","article-title":"Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1","volume":"324","author":"Tahiliani","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jtauto.2019.100015_bib68","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.cell.2011.08.042","article-title":"DNA demethylation dynamics","volume":"146","author":"Bhutani","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jtauto.2019.100015_bib69","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/s41467-018-04732-5","article-title":"DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis","volume":"9","author":"Kular","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtauto.2019.100015_bib70","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/nature08990","article-title":"Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis","volume":"464","author":"Baranzini","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jtauto.2019.100015_bib71","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/s41467-019-09984-3","article-title":"DNA methylation signatures of monozygotic twins clinically discordant for multiple sclerosis","volume":"10","author":"Souren","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtauto.2019.100015_bib72","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12863-016-0395-0","article-title":"Repetitive element hypermethylation in multiple sclerosis patients","volume":"17","author":"Neven","year":"2016","journal-title":"BMC Genet."},{"key":"10.1016\/j.jtauto.2019.100015_bib73","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jns.2009.12.018","article-title":"Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis","volume":"290","author":"Liggett","year":"2010","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.jtauto.2019.100015_bib74","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.bbadis.2014.04.010","article-title":"TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells","volume":"1842","author":"Calabrese","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jtauto.2019.100015_bib75","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2015.11.018","article-title":"Expression of DNA methylation genes in secondary progressive multiple sclerosis","volume":"290","author":"Fagone","year":"2016","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib76","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4049\/jimmunol.1000960","article-title":"Profiling of CD4+ T cells with epigenetic immune lineage analysis","volume":"186","author":"Janson","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib77","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2012.03.003","article-title":"Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects","volume":"246","author":"Kumagai","year":"2012","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117403","article-title":"Genome-wide DNA methylation profiles indicate CD8+ T cell hypermethylation in multiple sclerosis","volume":"10","author":"Bos","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2019.100015_bib79","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1177\/1352458513516529","article-title":"Methylation differences at the HLA-DRB1 locus in CD4+ T-Cells are associated with multiple sclerosis","volume":"20","author":"Graves","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jtauto.2019.100015_bib80","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ebiom.2019.04.042","article-title":"Combining evidence from four immune cell types identifies DNA methylation patterns that implicate functionally distinct pathways during Multiple Sclerosis progression","volume":"43","author":"Ewing","year":"2019","journal-title":"EBioMed"},{"key":"10.1016\/j.jtauto.2019.100015_bib81","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/jnr.21329","article-title":"Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated","volume":"85","author":"Mastronardi","year":"2007","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.jtauto.2019.100015_bib82","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nn.3588","article-title":"Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains","volume":"17","author":"Huynh","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jtauto.2019.100015_bib83","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaut.2017.05.005","article-title":"Methylome and transcriptome profiling in Myasthenia Gravis monozygotic twins","volume":"82","author":"Mamrut","year":"2017","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jtauto.2019.100015_bib84","article-title":"CTLA-4 methylation regulates the pathogenesis of myasthenia gravis and the expression of related cytokines","volume":"97","author":"Fang","year":"2018","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jtauto.2019.100015_bib85","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/5584_2017_58","article-title":"Histone post-translational modifications and nucleosome organisation in transcriptional regulation: some open questions","volume":"966","author":"Castillo","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jtauto.2019.100015_bib86","doi-asserted-by":"crossref","first-page":"15170","DOI":"10.1523\/JNEUROSCI.4349-14.2015","article-title":"Changes in methionine metabolism and histone H3 trimethylation are linked to mitochondrial defects in multiple sclerosis","volume":"35","author":"Singhal","year":"2015","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jtauto.2019.100015_bib87","doi-asserted-by":"crossref","first-page":"11387","DOI":"10.1523\/JNEUROSCI.3349-06.2006","article-title":"Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation","volume":"26","author":"Mastronardi","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jtauto.2019.100015_bib88","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/acs.jproteome.7b00270","article-title":"Increased post-translational lysine acetylation of myelin basic protein is associated with peak neurological disability in a mouse experimental autoimmune encephalomyelitis model of multiple sclerosis","volume":"17","author":"Lillico","year":"2018","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.jtauto.2019.100015_bib89","article-title":"Role of HDAC3 on p53 expression and apoptosis in T cells of patients with multiple sclerosis","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2019.100015_bib90","first-page":"2380","article-title":"Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production","volume":"14","author":"Saemann","year":"2000","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.jtauto.2019.100015_bib91","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1523\/JNEUROSCI.4507-10.2011","article-title":"Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions","volume":"31","author":"Pedre","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jtauto.2019.100015_bib92","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12026-014-8557-5","article-title":"Role of SIRT1 in autoimmune demyelination and neurodegeneration","volume":"61","author":"Martin","year":"2015","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jtauto.2019.100015_bib93","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.yexmp.2017.01.014","article-title":"SIRT1 as a potential biomarker of response to treatment with glatiramer acetate in multiple sclerosis","volume":"102","author":"Hewes","year":"2017","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.jtauto.2019.100015_bib94","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/or.2016.5236","article-title":"Non-coding RNAs as regulators in epigenetics","volume":"37","author":"Wei","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jtauto.2019.100015_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007440","article-title":"Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls","volume":"4","author":"Keller","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2019.100015_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024604","article-title":"Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis","volume":"6","author":"Waschbisch","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2019.100015_bib97","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/ni.1798","article-title":"MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis","volume":"10","author":"Du","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib98","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-981-10-5987-2_5","article-title":"miR-155 dysregulation and therapeutic intervention in multiple sclerosis","volume":"1024","author":"McCoy","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jtauto.2019.100015_bib99","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1128\/MCB.00824-12","article-title":"MiR-146a and NF-kappaB1 regulate mast cell survival and T lymphocyte differentiation","volume":"32","author":"Rusca","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jtauto.2019.100015_bib100","doi-asserted-by":"crossref","first-page":"34503","DOI":"10.1038\/srep34503","article-title":"MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis","volume":"6","author":"Lecca","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2019.100015_bib101","article-title":"Analysis of miRNA in normal appearing white matter to identify altered CNS pathways in multiple sclerosis","volume":"1","author":"Guerau-de-Arellano","year":"2015","journal-title":"J.\u00a0Autoimmune Dis."},{"key":"10.1016\/j.jtauto.2019.100015_bib102","doi-asserted-by":"crossref","first-page":"724715","DOI":"10.1155\/2015\/724715","article-title":"Detecting key genes regulated by miRNAs in dysfunctional crosstalk pathway of myasthenia gravis","volume":"2015","author":"Cao","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.jtauto.2019.100015_bib103","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10875-012-9834-5","article-title":"MiR-320a is downregulated in patients with myasthenia gravis and modulates inflammatory cytokines production by targeting mitogen-activated protein kinase 1","volume":"33","author":"Cheng","year":"2013","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib104","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neulet.2013.09.014","article-title":"Altered expression of miR-146a in myasthenia gravis","volume":"555","author":"Lu","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jtauto.2019.100015_bib105","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.clim.2015.12.009","article-title":"MiR-15a contributes abnormal immune response in myasthenia gravis by targeting CXCL10","volume":"164","author":"Liu","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib106","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1684\/ecn.2015.0367","article-title":"Disease-specific signature of serum miR-20b and its targets IL-8 and IL-25, in myasthenia gravis patients","volume":"26","author":"Chunjie","year":"2015","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.jtauto.2019.100015_bib107","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10238-015-0358-1","article-title":"Decreased microRNA miR-181c expression in peripheral blood mononuclear cells correlates with elevated serum levels of IL-7 and IL-17 in patients with myasthenia gravis","volume":"16","author":"Zhang","year":"2016","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.jtauto.2019.100015_bib108","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.autrev.2018.01.008","article-title":"Analysis of microRNA expression in the thymus of Myasthenia Gravis patients opens new research avenues","volume":"17","author":"Cron","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2019.100015_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205464","article-title":"MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis","volume":"13","author":"Sengupta","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2019.100015_bib110","doi-asserted-by":"crossref","first-page":"9595718","DOI":"10.1155\/2016\/9595718","article-title":"miR-20b inhibits T cell proliferation and activation via NFAT signaling pathway in thymoma-associated myasthenia gravis","volume":"2016","author":"Xin","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.jtauto.2019.100015_bib111","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12974-015-0418-1","article-title":"Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis","volume":"12","author":"Keller","year":"2015","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.jtauto.2019.100015_bib112","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.12659\/MSM.904642","article-title":"MicroRNAs correlate with multiple sclerosis and neuromyelitis optica spectrum disorder in a Chinese population","volume":"23","author":"Chen","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.jtauto.2019.100015_bib113","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12974-016-0648-x","article-title":"Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO)","volume":"13","author":"Vaknin-Dembinsky","year":"2016","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.jtauto.2019.100015_bib114","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1172\/JCI200114235","article-title":"Mechanisms for the induction of autoimmunity by infectious agents","volume":"108","author":"Wucherpfennig","year":"2001","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.jtauto.2019.100015_bib115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12016-011-8294-7","article-title":"Molecular mimicry as a mechanism of autoimmune disease","volume":"42","author":"Cusick","year":"2012","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib116","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0065-3527(01)56008-X","article-title":"Virus-induced autoimmunity: epitope spreading to myelin autoepitopes in Theiler\u2019s virus infection of the central nervous system","volume":"56","author":"Miller","year":"2001","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.jtauto.2019.100015_bib117","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08916930500484799","article-title":"Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation","volume":"39","author":"McCoy","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jtauto.2019.100015_bib118","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/WCO.0000000000000553","article-title":"Neurological syndromes driven by postinfectious processes or unrecognized persistent infections","volume":"31","author":"Johnson","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jtauto.2019.100015_bib119","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nrneurol.2012.198","article-title":"The initiation and prevention of multiple sclerosis","volume":"8","author":"Ascherio","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jtauto.2019.100015_bib120","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ana.21978","article-title":"Primary infection with the Epstein-Barr virus and risk of multiple sclerosis","volume":"67","author":"Levin","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jtauto.2019.100015_bib121","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.msard.2018.06.014","article-title":"Multiple sclerosis is caused by three-hits, strictly in order, in genetically susceptible persons","volume":"24","author":"Kearns","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jtauto.2019.100015_bib122","doi-asserted-by":"crossref","first-page":"9439","DOI":"10.1128\/JVI.79.15.9439-9448.2005","article-title":"Variant-specific tropism of human herpesvirus 6 in human astrocytes","volume":"79","author":"Donati","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jtauto.2019.100015_bib123","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12985-017-0719-3","article-title":"Multiple sclerosis: an example of pathogenic viral interaction?","volume":"14","author":"Fierz","year":"2017","journal-title":"Virol. J."},{"key":"10.1016\/j.jtauto.2019.100015_bib124","doi-asserted-by":"crossref","first-page":"95432","DOI":"10.18632\/oncotarget.20731","article-title":"Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator?","volume":"8","author":"Cavalcante","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtauto.2019.100015_bib125","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/jnnp-2014-308095","article-title":"Epstein-Barr virus persistence and reactivation in neuromyelitis optica","volume":"86","author":"Masuda","year":"2015","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jtauto.2019.100015_bib126","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jns.2018.09.028","article-title":"Concurrent Guillain-Barre syndrome, transverse myelitis and encephalitis post-Zika: a case report and review of the pathogenic role of multiple arboviral immunity","volume":"395","author":"Mancera-Paez","year":"2018","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.jtauto.2019.100015_bib127","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fnmol.2018.00116","article-title":"Autoimmune neurological conditions associated with Zika virus infection","volume":"11","author":"Acosta-Ampudia","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jtauto.2019.100015_bib128","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(00)02036-5","article-title":"Neurological manifestations of dengue infection","volume":"355","author":"Solomon","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jtauto.2019.100015_bib129","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4269\/ajtmh.15-0753","article-title":"Guillain-barre syndrome and chikungunya: description of all cases diagnosed during the 2014 outbreak in the French west Indies","volume":"97","author":"Balavoine","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jtauto.2019.100015_bib130","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/cid\/cit512","article-title":"Hepatitis E and guillain-barre syndrome","volume":"57","author":"Geurtsvankessel","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jtauto.2019.100015_bib131","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.0954-6820.1967.tb07283.x","article-title":"The Guillain-Barre syndrome associated with acquired cytomegalovirus infection","volume":"181","author":"Klemola","year":"1967","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.jtauto.2019.100015_bib132","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/cid\/cir074","article-title":"Guillain-Barre syndrome following primary cytomegalovirus infection: a prospective cohort study","volume":"52","author":"Orlikowski","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jtauto.2019.100015_bib133","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1212\/WNL.0000000000000566","article-title":"Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barre syndrome","volume":"83","author":"Sawai","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2019.100015_bib134","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneuroim.2018.02.003","article-title":"Neuromyelitis optica spectrum disorder associated with dengue virus infection","volume":"318","author":"Lana-Peixoto","year":"2018","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib135","first-page":"1251","article-title":"Myasthenia gravis and infectious disease","volume":"265","author":"Gilhus","year":"2018","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.jtauto.2019.100015_bib136","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1172\/JCI114282","article-title":"Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus","volume":"84","author":"Schwimmbeck","year":"1989","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.jtauto.2019.100015_bib137","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/mus.23869","article-title":"West nile virus infection and myasthenia gravis","volume":"49","author":"Leis","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jtauto.2019.100015_bib138","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1212\/WNL.0000000000003697","article-title":"Zika virus infection and myasthenia gravis: report of 2 cases","volume":"88","author":"Molko","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2019.100015_bib139","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1212\/WNL.56.9.1126","article-title":"Chlamydia pneumoniae and its proposed link to multiple sclerosis: to be or not to be?","volume":"56","author":"Gaydos","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2019.100015_bib140","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/13813450701531227","article-title":"Systemic infections in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"113","author":"Tauber","year":"2007","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.jtauto.2019.100015_bib141","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/135245850100700103","article-title":"Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker","volume":"7","author":"Krametter","year":"2001","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jtauto.2019.100015_bib142","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jns.2003.09.012","article-title":"Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms","volume":"217","author":"Fainardi","year":"2004","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.jtauto.2019.100015_bib143","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/brain\/124.7.1325","article-title":"Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response","volume":"124","author":"Derfuss","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.jtauto.2019.100015_bib144","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.20020393","article-title":"Chlamydia pneumoniae infection of the central nervous system worsens experimental allergic encephalitis","volume":"196","author":"Du","year":"2002","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jtauto.2019.100015_bib145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.188.2.305","article-title":"Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure","volume":"188","author":"Kengatharan","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jtauto.2019.100015_bib146","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/brain\/124.8.1544","article-title":"Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis","volume":"124","author":"Schrijver","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.jtauto.2019.100015_bib147","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1182\/blood.V90.3.1246","article-title":"Expression and intracellular localization of the human N-acetylmuramyl-L-alanine amidase, a bacterial cell wall-degrading enzyme","volume":"90","author":"Hoijer","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jtauto.2019.100015_bib148","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1128\/IAI.00026-06","article-title":"Streptococcus pneumoniae Infection aggravates experimental autoimmune encephalomyelitis via Toll-like receptor 2","volume":"74","author":"Herrmann","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jtauto.2019.100015_bib149","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/bmj.285.6336.173","article-title":"Guillain-Barre syndrome associated with Campylobacter infection","volume":"285","author":"Rhodes","year":"1982","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jtauto.2019.100015_bib150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/504294","article-title":"Incidence of Guillain-Barre syndrome among patients with Campylobacter infection: a general practice research database study","volume":"194","author":"Tam","year":"2006","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.jtauto.2019.100015_bib151","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barre syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jtauto.2019.100015_bib152","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1074\/jbc.M108452200","article-title":"The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide","volume":"277","author":"Gilbert","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jtauto.2019.100015_bib153","doi-asserted-by":"crossref","first-page":"748","DOI":"10.4049\/jimmunol.0903014","article-title":"TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation","volume":"185","author":"Kuijf","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib154","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1586\/1744666X.2013.811119","article-title":"Infectious and noninfectious triggers in Guillain-Barre syndrome","volume":"9","author":"Wakerley","year":"2013","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib155","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3855\/jidc.1508","article-title":"The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain-Barre syndrome","volume":"5","author":"Sharma","year":"2011","journal-title":"J.\u00a0Infect. Dev. Ctries."},{"key":"10.1016\/j.jtauto.2019.100015_bib156","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaut.2016.12.007","article-title":"A\u00a0comprehensive analysis and immunobiology of autoimmune neurological syndromes during the Zika virus outbreak in Cucuta, Colombia","volume":"77","author":"Anaya","year":"2017","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jtauto.2019.100015_bib157","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.57.4.736","article-title":"Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry","volume":"57","author":"Kusunoki","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2019.100015_bib158","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1016\/j.febslet.2014.03.018","article-title":"Microbial and dietary factors modulating intestinal regulatory T cell homeostasis","volume":"588","author":"Kinoshita","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jtauto.2019.100015_bib159","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.immuni.2017.04.008","article-title":"Homeostatic immunity and the microbiota","volume":"46","author":"Belkaid","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.jtauto.2019.100015_bib160","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12974-019-1434-3","article-title":"Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis","volume":"16","author":"Ma","year":"2019","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.jtauto.2019.100015_bib161","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009759","article-title":"The gut microbiota influences blood-brain barrier permeability in mice","volume":"6","author":"Braniste","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jtauto.2019.100015_bib162","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature10554","article-title":"Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination","volume":"479","author":"Berer","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jtauto.2019.100015_bib163","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cen3.12499","article-title":"Role of diet, gut microbiota, and metabolism in multiple sclerosis and neuromyelitis optica","volume":"10","author":"Okuno","year":"2019","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib164","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137429","article-title":"Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters","volume":"10","author":"Miyake","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2019.100015_bib165","doi-asserted-by":"crossref","first-page":"12015","DOI":"10.1038\/ncomms12015","article-title":"Alterations of the human gut microbiome in multiple sclerosis","volume":"7","author":"Jangi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtauto.2019.100015_bib166","doi-asserted-by":"crossref","first-page":"28484","DOI":"10.1038\/srep28484","article-title":"Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2019.100015_bib167","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12883-016-0703-3","article-title":"Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls","volume":"16","author":"Tremlett","year":"2016","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jtauto.2019.100015_bib168","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076359","article-title":"Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease","volume":"8","author":"Rumah","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2019.100015_bib169","first-page":"88","article-title":"Intestinal microbiota in multiple sclerosis: influence of treatment with interferon \u03b2-1b","volume":"22","author":"\u00c1lvarez","year":"2016","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.jtauto.2019.100015_bib170","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1073\/pnas.1711235114","article-title":"Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models","volume":"114","author":"Cekanaviciute","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.jtauto.2019.100015_bib171","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.3389\/fmicb.2018.02627","article-title":"Altered gut microbiota in myasthenia gravis","volume":"9","author":"Qiu","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jtauto.2019.100015_bib172","doi-asserted-by":"crossref","first-page":"14384","DOI":"10.1038\/s41598-018-32700-y","article-title":"Fecal microbiota profile in a group of myasthenia gravis patients","volume":"8","author":"Moris","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2019.100015_bib173","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s13311-017-0594-z","article-title":"The gut microbiome in neuromyelitis optica","volume":"15","author":"Zamvil","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jtauto.2019.100015_bib174","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ana.24718","article-title":"Gut microbiome analysis in neuromyelitis optica reveals overabundance of Clostridium perfringens","volume":"80","author":"Cree","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jtauto.2019.100015_bib175","article-title":"Lack of short-chain fatty acids and overgrowth of opportunistic pathogens define dysbiosis of neuromyelitis optica spectrum disorders: a Chinese pilot study","author":"Gong","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jtauto.2019.100015_bib176","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016149","article-title":"Smoking and multiple sclerosis: an updated meta-analysis","volume":"6","author":"Handel","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2019.100015_bib177","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s10654-013-9853-4","article-title":"Smoking and multiple sclerosis susceptibility","volume":"28","author":"Hedstrom","year":"2013","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.jtauto.2019.100015_bib178","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1212\/WNL.0b013e3181b59c40","article-title":"Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis","volume":"73","author":"Hedstrom","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2019.100015_bib179","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/01.wnl.0000233834.09743.3b","article-title":"The risk of relapses in multiple sclerosis during systemic infections","volume":"67","author":"Correale","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2019.100015_bib180","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jneuroim.2015.03.006","article-title":"Smoking worsens multiple sclerosis prognosis: two different pathways are involved","volume":"281","author":"Correale","year":"2015","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib181","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaut.2018.09.005","article-title":"GPR15(+) T cells are Th17 like, increased in smokers and associated with multiple sclerosis","volume":"97","author":"Ammitzboll","year":"2019","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jtauto.2019.100015_bib182","first-page":"1508","article-title":"Mortality of patients with multiple sclerosis: a cohort study in UK primary care","volume":"261","author":"Jick","year":"2014","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.jtauto.2019.100015_bib183","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/WNO.0000000000000306","article-title":"Cigarette smoking and activities of daily living in ocular myasthenia gravis","volume":"36","author":"Gratton","year":"2016","journal-title":"J.\u00a0Neuro Ophthalmol."},{"key":"10.1016\/j.jtauto.2019.100015_bib184","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1468-1331.2012.03843.x","article-title":"Smoking and socio-economic status may affect myasthenia gravis","volume":"20","author":"Maniaol","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jtauto.2019.100015_bib185","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.autrev.2018.12.010","article-title":"Emerging role of air pollution in autoimmune diseases","volume":"18","author":"Zhao","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2019.100015_bib186","first-page":"782462","article-title":"The adverse effects of air pollution on the nervous system","volume":"2012","author":"Genc","year":"2012","journal-title":"J.\u00a0Toxicol."},{"key":"10.1016\/j.jtauto.2019.100015_bib187","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mehy.2017.01.003","article-title":"Multiple sclerosis and air pollution exposure: mechanisms toward brain autoimmunity","volume":"100","author":"Esmaeil Mousavi","year":"2017","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jtauto.2019.100015_bib188","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.envres.2018.01.040","article-title":"Ozone, NO2 and PM10 are associated with the occurrence of multiple sclerosis relapses. Evidence from seasonal multi-pollutant analyses","volume":"163","author":"Jeanjean","year":"2018","journal-title":"Environ. Res."},{"key":"10.1016\/j.jtauto.2019.100015_bib189","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.envres.2017.03.049","article-title":"Air pollution by particulate matter PM10 may trigger multiple sclerosis relapses","volume":"156","author":"Roux","year":"2017","journal-title":"Environ. Res."},{"key":"10.1016\/j.jtauto.2019.100015_bib190","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000067108","article-title":"Ambient air quality and occurrence of multiple sclerosis relapse","volume":"22","author":"Oikonen","year":"2003","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jtauto.2019.100015_bib191","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.envint.2017.07.013","article-title":"Exposure to particulate matter air pollution and risk of multiple sclerosis in two large cohorts of US nurses","volume":"109","author":"Palacios","year":"2017","journal-title":"Environ. Int."},{"key":"10.1016\/j.jtauto.2019.100015_bib192","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5603\/PJNNS.a2019.0015","article-title":"Vitamin D as an immune modulator in multiple sclerosis","volume":"53","author":"Bartosik-Psujek","year":"2019","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.jtauto.2019.100015_bib193","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1177\/1352458513509508","article-title":"Fatty fish intake is associated with decreased occurrence of multiple sclerosis","volume":"20","author":"Baarnhielm","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jtauto.2019.100015_bib194","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40120-017-0086-4","article-title":"Vitamin D and multiple sclerosis: a comprehensive review","volume":"7","author":"Sintzel","year":"2018","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.jtauto.2019.100015_bib195","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/abbi.1999.1605","article-title":"Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system","volume":"374","author":"Veldman","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jtauto.2019.100015_bib196","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3389\/fimmu.2018.00477","article-title":"Genomic effects of the vitamin D receptor: potentially the link between vitamin D, immune cells, and multiple sclerosis","volume":"9","author":"Lu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib197","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/eji.201040632","article-title":"1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis","volume":"41","author":"Mayne","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib198","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.msard.2013.08.009","article-title":"Genetic evidence for a pathogenic role for the vitamin D3 metabolizing enzyme CYP24A1 in multiple sclerosis","volume":"3","author":"Ramasamy","year":"2014","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jtauto.2019.100015_bib199","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000369","article-title":"Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D","volume":"5","author":"V Ramagopalan","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jtauto.2019.100015_bib200","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/jnnp-2012-303068","article-title":"Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis","volume":"83","author":"Decard","year":"2012","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jtauto.2019.100015_bib201","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/1352458516654310","article-title":"Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis","volume":"23","author":"Rosjo","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jtauto.2019.100015_bib202","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1177\/1352458517722646","article-title":"Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis","volume":"24","author":"Rolf","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jtauto.2019.100015_bib203","first-page":"294","article-title":"Low serum vitamin D levels in patients with myasthenia gravis","volume":"50","author":"Kang","year":"2018","journal-title":"J.\u00a0Clin. Neurosci. Off. J. Neurosurg. Soc. Australas."},{"key":"10.1016\/j.jtauto.2019.100015_bib204","first-page":"22","article-title":"Low levels of vitamin D and the relationship between vitamin D and Th2 axis-related cytokines in neuromyelitis optica spectrum disorders","volume":"61","author":"Gao","year":"2019","journal-title":"J.\u00a0Clin. Neurosci. Off. J. Neurosurg. Soc. Australas."},{"key":"10.1016\/j.jtauto.2019.100015_bib205","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jns.2005.03.009","article-title":"Vitamin B12, demyelination, remyelination and repair in multiple sclerosis","volume":"233","author":"Miller","year":"2005","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.jtauto.2019.100015_bib206","doi-asserted-by":"crossref","DOI":"10.46867\/IJCP.2007.20.02.15","article-title":"Endocrinology of stress","volume":"20","author":"Romero","year":"2007","journal-title":"Int. J. Comp. Psychol."},{"key":"10.1016\/j.jtauto.2019.100015_bib207","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bbi.2005.03.011","article-title":"A\u00a0temporal framework for understanding the effects of stressful life events on inflammation in patients with multiple sclerosis","volume":"20","author":"Mohr","year":"2006","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jtauto.2019.100015_bib208","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5455\/msm.2012.24.142-147","article-title":"Stress as provoking factor for the first and repeated multiple sclerosis seizures","volume":"24","author":"Djelilovic-Vranic","year":"2012","journal-title":"Mater. Sociomed."},{"key":"10.1016\/j.jtauto.2019.100015_bib209","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jns.2009.10.012","article-title":"The effect of war stress on multiple sclerosis exacerbations and radiological disease activity","volume":"288","author":"Yamout","year":"2010","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.jtauto.2019.100015_bib210","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/08830181003746304","article-title":"Could autoimmunity be induced by vaccination?","volume":"29","author":"Salemi","year":"2010","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib211","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.vaccine.2018.02.036","article-title":"Hepatitis B vaccination and the putative risk of central demyelinating diseases - a systematic review and meta-analysis","volume":"36","author":"Mouchet","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jtauto.2019.100015_bib212","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1080\/21645515.2017.1423155","article-title":"Association between human papilloma virus (HPV) vaccination and risk of multiple sclerosis: a systematic review","volume":"14","author":"Meggiolaro","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.jtauto.2019.100015_bib213","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.4161\/hv.28961","article-title":"Acute disseminated encephalomyelitis with severe neurological outcomes following virosomal seasonal influenza vaccine","volume":"10","author":"Alicino","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.jtauto.2019.100015_bib214","first-page":"103","article-title":"Acute disseminated encephalomyelitis following meningococcal vaccination: case report and review of the literature","volume":"81","author":"Gnanajothy","year":"2017","journal-title":"Conn. Med."},{"key":"10.1016\/j.jtauto.2019.100015_bib215","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/0264-410X(93)90163-R","article-title":"Acute encephalopathy and chronic neurological damage after pertussis vaccine","volume":"11","author":"Cowan","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.jtauto.2019.100015_bib216","first-page":"106","article-title":"Biphasic demyelination of the nervous system following anti-rabies vaccination","volume":"52","author":"Kulkarni","year":"2004","journal-title":"Neurol. India"},{"key":"10.1016\/j.jtauto.2019.100015_bib217","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/01.inf.0000130941.72712.33","article-title":"Possible association of Guillain-Barre syndrome and hepatitis A vaccination","volume":"23","author":"Blumenthal","year":"2004","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.jtauto.2019.100015_bib218","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.clineuro.2003.11.002","article-title":"Guillain-Barre syndrome coexisting with pericarditis or nephrotic syndrome after influenza vaccination","volume":"106","author":"Kao","year":"2004","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jtauto.2019.100015_bib219","first-page":"265","article-title":"Human papillomavirus vaccines and Guillain-Barre syndrome: managing uncertainties","volume":"25","year":"2016","journal-title":"Prescrire Int."},{"key":"10.1016\/j.jtauto.2019.100015_bib220","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/archinte.166.20.2217","article-title":"Guillain-Barre syndrome after influenza vaccination in adults: a population-based study","volume":"166","author":"Juurlink","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jtauto.2019.100015_bib221","first-page":"387","article-title":"D-penicillamine induced myasthenia gravis: clinical, serological and genetic findings","volume":"11","author":"Drosos","year":"1993","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jtauto.2019.100015_bib222","series-title":"Ann. N. Y. Acad. Sci.","first-page":"433","article-title":"Drug-induced autoimmune myasthenia gravis","author":"Penn","year":"1998"},{"key":"10.1016\/j.jtauto.2019.100015_bib223","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/BOR.0000000000000108","article-title":"The causes of drug-induced muscle toxicity","volume":"26","author":"Jones","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jtauto.2019.100015_bib224","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/mus.21584","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists","volume":"41","author":"Alshekhlee","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jtauto.2019.100015_bib225","doi-asserted-by":"crossref","first-page":"179180","DOI":"10.1155\/2014\/179180","article-title":"New onset of dermatomyositis\/polymyositis during anti-TNF-\u03b1 therapies: a systematic literature review","volume":"2014","author":"Brunasso","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.jtauto.2019.100015_bib226","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.pjnns.2015.08.006","article-title":"Acute liver failure and liver transplantation in a patient with multiple sclerosis treated with interferon beta","volume":"49","author":"Kozielewicz","year":"2015","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.jtauto.2019.100015_bib227","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1212\/NXI.0000000000000371","article-title":"Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis","volume":"4","author":"Joubert","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflammation."},{"key":"10.1016\/j.jtauto.2019.100015_bib228","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187503","article-title":"Mutational analysis of ITPR1 in a Taiwanese cohort with cerebellar ataxias","volume":"12","author":"Hsiao","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2019.100015_bib229","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fimmu.2017.00395","article-title":"Advances in autoimmune epilepsy associated with antibodies, their potential pathogenic molecular mechanisms, and current recommended immunotherapies","volume":"8","author":"Fang","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib230","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.4103\/0028-3886.246252","article-title":"Focus on neuro-Behcet\u2019s disease: a review","volume":"66","author":"Caruso","year":"2018","journal-title":"Neurol. India"},{"key":"10.1016\/j.jtauto.2019.100015_bib231","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3899\/jrheum.140949","article-title":"Variants of the IFI16 gene affecting the levels of expression of mRNA are associated with susceptibility to Behcet disease","volume":"42","author":"Ortiz-Fernandez","year":"2015","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jtauto.2019.100015_bib232","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.624","article-title":"Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet\u2019s disease susceptibility loci","volume":"42","author":"Mizuki","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jtauto.2019.100015_bib233","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ng.625","article-title":"Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet\u2019s disease","volume":"42","author":"Remmers","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jtauto.2019.100015_bib234","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng.2520","article-title":"Genome-wide association analysis identifies new susceptibility loci for Behcet\u2019s disease and epistasis between HLA-B*51 and ERAP1","volume":"45","author":"Kirino","year":"2013","journal-title":"Nat. Genet."},{"issue":"Suppl 1","key":"10.1016\/j.jtauto.2019.100015_bib235","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1529-8027.2011.00308.x","article-title":"Polymorphism of transient axonal glycoprotein-1 in chronic inflammatory demyelinating polyneuropathy","volume":"16","author":"Iijima","year":"2011","journal-title":"J.\u00a0Peripher. Nerv. Syst."},{"key":"10.1016\/j.jtauto.2019.100015_bib236","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.transci.2013.07.024","article-title":"Association of HLA-DR\/DQ polymorphism with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in Tunisian patients","volume":"49","author":"Mrad","year":"2013","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.jtauto.2019.100015_bib237","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jneuroim.2008.04.003","article-title":"Susceptibility to chronic inflammatory demyelinating polyradiculoneuropathy is associated to polymorphic GA repeat in the SH2D2A gene","volume":"197","author":"Notturno","year":"2008","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib238","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0198-8859(01)00270-1","article-title":"HLA class I and II in Lambert-Eaton myasthenic syndrome without associated tumor","volume":"62","author":"Wirtz","year":"2001","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib239","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/art.1780390910","article-title":"Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis","volume":"39","author":"Arnett","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2019.100015_bib240","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/ar3327","article-title":"Recent advances in the immunogenetics of idiopathic inflammatory myopathy","volume":"13","author":"Chinoy","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2019.100015_bib241","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1002\/art.24039","article-title":"Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis","volume":"58","author":"Mamyrova","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2019.100015_bib242","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1046\/j.1523-1747.2002.19608.x","article-title":"Mannose binding lectin (MBL) polymorphisms associated with low MBL production in patients with dermatomyositis","volume":"119","author":"Werth","year":"2002","journal-title":"J.\u00a0Investig. Dermatol."},{"key":"10.1016\/j.jtauto.2019.100015_bib243","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1002\/art.23900","article-title":"The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients","volume":"58","author":"Chinoy","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2019.100015_bib244","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1136\/annrheumdis-2011-200839","article-title":"Positive association between STAT4 polymorphisms and polymyositis\/dermatomyositis in a Japanese population","volume":"71","author":"Sugiura","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2019.100015_bib245","article-title":"Genetic association study of TNFAIP3, IFIH1, IRF5 polymorphisms with polymyositis\/dermatomyositis in Chinese Han population","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2019.100015_bib246","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41439-018-0033-7","article-title":"Genetics of narcolepsy","volume":"6","author":"Miyagawa","year":"2019","journal-title":"Hum. Genome Var."},{"key":"10.1016\/j.jtauto.2019.100015_bib247","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003270","article-title":"ImmunoChip study implicates antigen presentation to T cells in narcolepsy","volume":"9","author":"Faraco","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jtauto.2019.100015_bib248","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ng.734","article-title":"Common variants in P2RY11 are associated with narcolepsy","volume":"43","author":"Kornum","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jtauto.2019.100015_bib249","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsy019","article-title":"Epigenome-wide association study of DNA methylation in narcolepsy: an integrated genetic and epigenetic approach","volume":"41","author":"Shimada","year":"2018","journal-title":"Sleep"},{"key":"10.1016\/j.jtauto.2019.100015_bib250","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.5665\/sleep.4004","article-title":"miRNA profiles in plasma from patients with sleep disorders reveal dysregulation of miRNAs in narcolepsy and other central hypersomnias","volume":"37","author":"Holm","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/j.jtauto.2019.100015_bib251","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.sleep.2015.03.016","article-title":"MicroRNA expression is dysregulated in narcolepsy: a new evidence?","volume":"16","author":"Liguori","year":"2015","journal-title":"Sleep Med."},{"key":"10.1016\/j.jtauto.2019.100015_bib252","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1167\/iovs.16-21188","article-title":"Promoter hypermethylation of GATA3, IL-4, and TGF-beta confers susceptibility to vogt-koyanagi-harada disease in han Chinese","volume":"58","author":"Zhu","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jtauto.2019.100015_bib253","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/bjophthalmol-2017-311079","article-title":"MicroRNA-20a-5p suppresses IL-17 production by targeting OSM and CCL1 in patients with Vogt-Koyanagi-Harada disease","volume":"102","author":"Chang","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jtauto.2019.100015_bib254","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.brainresbull.2017.05.004","article-title":"MicroRNA-129-5p inhibits the development of autoimmune encephalomyelitis-related epilepsy by targeting HMGB1 through the TLR4\/NF-kB signaling pathway","volume":"132","author":"Liu","year":"2017","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jtauto.2019.100015_bib255","first-page":"411","article-title":"Increased complexin-1 and decreased miR-185 expression levels in Behcet\u2019s disease with and without neurological involvement","volume":"37","author":"Ugurel","year":"2016","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"10.1016\/j.jtauto.2019.100015_bib256","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jneuroim.2016.10.014","article-title":"MicroRNA expression profiling in Guillain-Barre syndrome","volume":"301","author":"Lv","year":"2016","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2019.100015_bib257","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.neurobiolaging.2008.08.021","article-title":"Decreased SIRT1 deacetylase activity in sporadic inclusion-body myositis muscle fibers","volume":"31","author":"Nogalska","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jtauto.2019.100015_bib258","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41232-017-0058-1","article-title":"Circulating plasma microRNA profiling in patients with polymyositis\/dermatomyositis before and after treatment: miRNA may be associated with polymyositis\/dermatomyositis","volume":"38","author":"Hirai","year":"2018","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.jtauto.2019.100015_bib259","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/art.38292","article-title":"Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies","volume":"66","author":"Georgantas","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2019.100015_bib260","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1159\/000452563","article-title":"MiR-146a regulates inflammatory infiltration by macrophages in polymyositis\/dermatomyositis by targeting TRAF6 and affecting IL-17\/ICAM-1 pathway","volume":"40","author":"Yin","year":"2016","journal-title":"Cell. Physiol. Biochem."}],"updated-by":[{"DOI":"10.1016\/j.jtauto.2020.100041","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000}}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909019300152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909019300152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:33:39Z","timestamp":1762904019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909019300152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":260,"alternative-id":["S2589909019300152"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2019.100015","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying the culprits in neurological autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2019.100015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100015"}}